Bio-Techne (TECH) Tops Q4 EPS by 25c

Bio-Techne (NASDAQ: TECH) reported Q4 EPS of $1.00, $0.25 better than the analyst estimate of $0.75. Revenue for the quarter came in at $175.8 million versus the consensus estimate of $163.91 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• Dare Bioscience (DARE) Tops Q2 EPS by 11c